MIRA INFORM REPORT

 

 

Report No. :

342085

Report Date :

26.09.2015

 

IDENTIFICATION DETAILS

 

Name :

MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED

 

 

Formerly Known As :

OZONE BIOMEDICALS PRIVATE LIMITED

 

 

Registered Office :

238 LGF, Sant Nagar, East of Kailash, New Delhi – 110065

Tel. No.:

91-129-4286600

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

07.05.2003

 

 

Com. Reg. No.:

55-120213

 

 

Capital Investment / Paid-up Capital :

Rs.15.000 Million

 

 

CIN No.:

[Company Identification No.]

U24239DL2003PTC120213

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

Not Available

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Trader of Medical Equipment.

 

 

No. of Employees :

Information declined by the management.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (28)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 34000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company incorporated in the year 2003. It has moderate track.

 

Management has reported satisfactory sales turnover and decent profit earnings.

 

The company has moderate financial position, negative reserves which led to weak debt protection metrics along with huge borrowings taken by the company.

 

Trade relations are fair. Business is active. Payment are slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

INFORMATION DENIED BY

 

Name :

Mr. Narendra Bharatwaj

Designation :

Account Manager

Contact No.:

91-129-4286600

Date :

24.09.2015

 

 

LOCATIONS

 

Registered Office :

238 LGF, Sant Nagar, East Of Kailash, New Delhi – 110065

Tel. No.:

Not Available

Fax No.:

Not Available

E-Mail :

diveshgupta@eth.net

Website :

www.ozonebio.com

 

 

Head Office :

Plot No 7, Site No. 2, 14/3 Milestone, Delhi Mathura Road, Faridabad – 121003, Haryana, India

Tel. No.:

91-129-4286600 / 4286609 / 4286618

Fax No.:

91-129-4049344

 

 

DIRECTORS

 

As on 30.09.2014

 

Name :

Mr. Shailesh Kumar Mittal

Designation :

Director

Address :

245, Kailash Hills, East Of Kailash, New Delhi - 110065, India

Date of Birth/Age :

17.02.1956

Date of Appointment :

04.03.2004

DIN No.:

00432708

Other Directorship :

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74899DL1984PTC018547

EMBEE DIAGNOSTICS PRIVATE LIMITED

Director

17/02/1986

17/02/1986

01/08/2010

Active

NO

2

U74899DL1988PTC031713

BSL AGENCIES PRIVATE LIMITED

Director

09/07/1990

09/07/1990

01/08/2010

Active

NO

3

U24231DL1997PTC085071

EMBEE HEALTHCARE PRIVATE LIMITED

Director

11/02/1997

11/02/1997

01/08/2010

Active

NO

4

U74899DL1995PLC071599

KRISONS TECHNOSOFT LIMITED

Director

15/03/2003

15/03/2003

31/03/2008

Active

NO

5

U24239DL2003PTC120213

MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED

Director

04/03/2004

04/03/2004

-

Active

NO

 

 

Name :

Mr. Prateek Kumar Mittal

Designation :

Director

Address :

245, Kailash Hills, East Of Kailash, New Delhi - 110065, India

Date of Birth/Age :

15.02.1981

Date of Appointment :

02.04.2007

DIN No.:

00639787

Other Directorship :

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24231DL1997PTC085071

EMBEE HEALTHCARE PRIVATE LIMITED

Director

19/02/2001

19/02/2001

01/08/2010

Active

NO

2

U74899DL1984PTC018547

EMBEE DIAGNOSTICS PRIVATE LIMITED

Director

09/04/2003

09/04/2003

01/08/2010

Active

NO

3

U24239DL2003PTC120213

MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED

Director

02/04/2007

02/04/2007

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Narendra Bharatwaj

Designation :

Account Manager

 

 

MAJOR SHAREHOLDERS

 

As on 30.09.2014

 

Names of Shareholders

 

No. of Shares

Bimla Devi

 

1000

Dr.Shailesh Kumar Mittal

 

388500

Mittal Rai Monika

 

157500

Rani Pravesh

 

9000

Manan Mittal

 

360470

Prateek Mittal

 

357500

Mohak Rai and Pravesh Rani

 

10

Shewta Rai and Sureeti Rai

 

10

Suresh Rai

 

1000

Embee Diagnsotics Private Limited

 

225000

Ramesh K Suri

 

10

Total

 

1500000

 

As on 30.09.2014

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Directors or relatives of Directors

85.00

Other top fifty shareholders

15.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Trader of Medical Equipment.

 

 

Products :

Medical Equipment

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

PRODUCTION STATUS = NOT AVAILABLE

 


 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

No. of Employees :

Information declined by the management.

 

 

Bankers :

Banker Name

Vijaya Bank

Branch Address

31/C, DDA Complex, Opposite Moolchand Hospital,  Defence Colony, New Delhi – 110024, India

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

  • Punjab National Bank, LCB ; A-9; Conn. Place, New Delhi, India

 

Auditors :

 

Name :

Divesh Kumar Gupta and Company

Chartered Accountants

Address :

210-A, Vardaan House, 7/28, Mahaveer Street, Ansari Road, Darya Ganj, New Delhi – 110002, India

Tel. No.:

91-11-23262504

Mobile No.:

91-9811560625

PAN No.:

AESPG6424J

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Associates/Subsidiaries :

Not Available

 

 

CAPITAL STRUCTURE

 

As on 31.03.2014

 

Authorised Capital:

No. of Shares

Type

Value

Amount

 

 

 

 

1900000

Equity Shares

Rs.10/- each

Rs.19.000 Million

 

Issued, Subscribed & Paid-up Capital:

No. of Shares

Type

Value

Amount

 

 

 

 

1500000

Equity Shares

Rs.10/- each

Rs.15.000 Million

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2014

31.03.2013

31.03.2012

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

15.000

15.000

15.000

(b) Reserves & Surplus

(3.032)

(9.341)

(16.551)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

11.968

5.659

(1.551)

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

51.596

53.943

55.721

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

17.112

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

51.596

53.943

72.833

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

8.419

7.255

7.826

(b) Trade payables

52.082

39.198

34.267

(c) Other current liabilities

11.415

6.929

5.769

(d) Short-term provisions

1.294

0.098

0.000

Total Current Liabilities (4)

73.210

53.480

47.862

 

 

 

 

TOTAL

136.774

113.082

119.144

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

13.088

11.200

13.229

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

1.418

1.528

1.452

(d)  Long-term Loan and Advances

1.293

1.335

1.326

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

15.799

14.063

16.007

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.197

0.335

0.266

(b) Inventories

40.698

34.241

32.465

(c) Trade receivables

67.073

55.138

64.300

(d) Cash and cash equivalents

3.113

1.283

0.226

(e) Short-term loans and advances

9.894

8.022

5.880

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

120.975

99.019

103.137

 

 

 

 

TOTAL

136.774

113.082

119.144

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

Turnover (Gross)

319.531

268.495

220.815

 

Other Income

 NA

NA

 NA

 

TOTAL

 NA

NA

 NA

 

 

 

 

 

EXPENSES

 NA

NA

 NA

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

19.196

19.183

18.615

 

 

 

 

 

 

FINANCIAL EXPENSES

9.334

9.552

11.330

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

9.862

9.631

7.285

 

 

 

 

 

 

DEPRECIATION/ AMORTISATION

2.147

2.398

2.476

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

7.715

7.231

4.809

 

 

 

 

 

 

TAX

1.404

0.022

0.046

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

6.311

7.209

4.855

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

4.20

4.80

3.23

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

 NA

NA

 NA

Cash generated from operations

 NA

NA

 NA

Net cash flows from

 NA

NA

 NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT/ Turnover (Gross))

(%)

1.98

2.68

2.20

 

 

 

 

 

Operating Profit Margin

(PBDIT / Turnover (Gross))

(%)

6.01

7.14

8.43

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

5.70

6.48

4.09

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.64

1.28

(3.10)

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

5.01

10.81

(40.97)

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.65

1.85

2.15

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

15.000

15.000

15.000

Reserves & Surplus

(16.551)

(9.341)

(3.032)

Net worth

(1.551)

5.659

11.968

 

 

 

 

long-term borrowings

55.721

53.943

51.596

Short term borrowings

7.826

7.255

8.419

Total borrowings

63.547

61.198

60.015

Debt/Equity ratio

(40.972)

10.814

5.015

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Turnover (Gross)

220.815

268.495

319.531

 

 

21.593

19.008

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Turnover (Gross)

220.815

268.495

319.531

Profit

4.855

7.209

6.311

 

2.20%

2.68%

1.98%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

----------------------

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

No

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

No

22

Conduct of the banking account

----------------------

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

----------------------

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

----------------------

33

Market information

----------------------

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10524270

22/09/2014

840,000.00

VIAJAY BANK

DEFENCE COLONY, OPPOSITE MOOLCHAND HOSPITAL, DELHI - 110024, INDIA

C26520148

2

10465890

31/10/2013

4,000,000.00

VIJAYA BANK

31/C, DDA COMPLEX, OPPOSITE MOOLCHAND HOSPITAL, DEFENCE COLONY, NEW DELHI - 110024, INDIA

B91853127

3

10343190

09/03/2012

549,000.00

VIJAYA BANK

31/C, DDA COMPLEX, OPP. MOOLCHAND HOSPITAL, DEFENCE COLONY, DELHI - 110024, INDIA

B35459031

4

10076549

01/04/2013 *

5,000,000.00

VIJAYA BANK

31/C, DDA COMPLEX, OPPOSITE MOOLCHAND HOSPITAL, DEFENCE COLONY, NEW DELHI - 110024, INDIA

B74639014

5

10076548

01/04/2013 *

20,000,000.00

VIJAYA BANK

31/C, DDA COMPLEX, OPPOSITE MOOLCHAND HOSPITAL, DEFENCE COLONY, NEW DELHI - 110024, INDIA

B74639048

 

* Date of charge modification

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration:

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration:

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime:

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws:

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards:

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government:

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package:

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report:

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.09

UK Pound

1

Rs.100.88

Euro

1

Rs.73.95

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

TRI

 

 

Report Prepared by :

PNM


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILITY 

1~10

4

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

2

--RESERVES

1~10

---

--CREDIT LINES

1~10

3

--MARGINS

-5~5

---

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

28

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.